A Review of the Value of D-dimer Testing for Prediction of Recurrent Venous Thromboembolism with Increasing Age

Giuseppe Lippi; Emmanuel J. Favaloro; Gianfranco Cervellin

doi:10.1055/s-0034-1384630

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2014; 40(06): 634-639
DOI: 10.1055/s-0034-1384630

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

A Review of the Value of D-dimer Testing for Prediction of Recurrent Venous Thromboembolism with Increasing Age

Authors

Giuseppe Lippi

¹Laboratory of Clinical Chemistry and Hematology, Academic Hospital of Parma, Parma, Italy
Emmanuel J. Favaloro

²Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Pathology West, Westmead Hospital, Westmead, New South Wales, Australia
Gianfranco Cervellin

³Emergency Department, Academic Hospital of Parma, Parma, Italy

Abstract

Recurrent thrombosis is a relatively frequent complication of venous thromboembolism (VTE) and represents an important cause of clinical and economic issues for health care systems worldwide. Rates of thrombosis increase with increasing age, with aging recognized to be a risk factor for thrombosis. Although D-dimer is now regarded as the biochemical gold standard for assisting the diagnosis of VTE and predicting the recurrent risk of thrombosis, the interpretation of D-dimer values with increasing age remains challenging due to many factors. These include the development of age-related changes in both the microcirculation and blood coagulation, which ultimately contribute to generate a hypercoagulable state and a gradual increase of D-dimer concentration with aging. Convincing evidence has now been provided that while D-dimer values may be effectively utilized for predicting the risk of recurrent thrombosis with increasing age, conventional cutoff values are inappropriate for older populations. In summary, analysis of the current scientific literature suggests that the adoption of age-dependent thresholds may increase the diagnostic effectiveness of this biomarker with increasing age.

Keywords

D-dimer - venous thromboembolism - thrombosis - older people - aging

Full Text

References

References
1 Deitelzweig SB, Johnson BH, Lin J, Schulman KL. Prevalence of clinical venous thromboembolism in the USA: current trends and future projections. Am J Hematol 2011; 86 (2) 217-220
2 Montagnana M, Favaloro EJ, Franchini M, Guidi GC, Lippi G. The role of ethnicity, age and gender in venous thromboembolism. J Thromb Thrombolysis 2010; 29 (4) 489-496
3 White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107 (23) (Suppl. 01) I4-I8
4 Lippi G, Franchini M. Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost 2008; 34 (8) 747-761
5 Lippi G, Franchini M, Favaloro EJ. Unsuspected triggers of venous thromboembolism—trivial or not so trivial?. Semin Thromb Hemost 2009; 35 (7) 597-604
6 Lippi G, Franchini M, Favaloro EJ. Holiday thrombosis. Semin Thromb Hemost 2011; 37 (8) 869-874
7 Favaloro EJ, Franchini M, Lippi G. Coagulopathies and thrombosis: usual and unusual causes and associations. Part V. Semin Thromb Hemost 2011; 37 (8) 859-862
8 Silverstein RL, Bauer KA, Cushman M, Esmon CT, Ershler WB, Tracy RP. Venous thrombosis in the elderly: more questions than answers. Blood 2007; 110 (9) 3097-3101
9 Spencer FA, Gore JM, Lessard D , et al. Venous thromboembolism in the elderly. A community-based perspective. Thromb Haemost 2008; 100 (5) 780-788
10 López-Jiménez L, Montero M, González-Fajardo JA , et al; RIETE Investigators. Venous thromboembolism in very elderly patients: findings from a prospective registry (RIETE). Haematologica 2006; 91 (8) 1046-1051
11 Piazza G, Seddighzadeh A, Goldhaber SZ. Deep-vein thrombosis in the elderly. Clin Appl Thromb Hemost 2008; 14 (4) 393-398
12 Engbers MJ, van Hylckama Vlieg A, Rosendaal FR. Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost 2010; 8 (10) 2105-2112
13 Bauer KA, Weiss LM, Sparrow D, Vokonas PS, Rosenberg RD. Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study. J Clin Invest 1987; 80 (6) 1527-1534
14 Bates SM. D-dimer assays in diagnosis and management of thrombotic and bleeding disorders. Semin Thromb Hemost 2012; 38 (7) 673-682
15 Lippi G, Cervellin G, Casagranda I, Morelli B, Testa S, Tripodi A. D-dimer testing for suspected venous thromboembolism in the emergency department. Consensus document of AcEMC, CISMEL, SIBioC, and SIMeL. Clin Chem Lab Med 2014; 52 (5) 621-628
16 Lippi G, Favaloro EJ. D-dimer measurement and laboratory feedback. J Emerg Med 2009; 37 (1) 82-83 , author reply 83
17 Lippi G, Bonfanti L, Saccenti C, Cervellin G. Causes of elevated D-dimer in patients admitted to a large urban emergency department. Eur J Intern Med 2014; 25 (1) 45-48
18 Favaloro EJ. Laboratory testing in disseminated intravascular coagulation. Semin Thromb Hemost 2010; 36 (4) 458-467
19 Schouten HJ, Geersing GJ, Koek HL , et al. Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis. BMJ 2013; 346: f2492
20 Polo Friz H, Pasciuti L, Meloni DF , et al. A higher d-dimer threshold safely rules-out pulmonary embolism in very elderly emergency department patients. Thromb Res 2014; 133 (3) 380-383
21 Cini M, Legnani C, Frascaro M, Sartori M, Cosmi B, Palareti G. D-dimer use for deep venous thrombosis exclusion in elderly patients: a comparative analysis of three different approaches to establish cut-off values for an assay with results expressed in D-dimer units. Int J Lab Hematol 2014; doi: 10.1111/ijlh.12184
22 Douketis J, Tosetto A, Marcucci M , et al. Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ 2011; 342: d813
23 Douketis J, Tosetto A, Marcucci M , et al. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism. Ann Intern Med 2010; 153 (8) 523-531
24 Ageno W, Squizzato A, Wells PS, Büller HR, Johnson G. The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH. J Thromb Haemost 2013; 11 (8) 1597-1602
25 Palareti G, Cosmi B, Legnani C , et al; PROLONG Investigators. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med 2006; 355 (17) 1780-1789
26 Legnani C, Palareti G, Cosmi B, Cini M, Tosetto A, Tripodi A ; PROLONG Investigators (FCSA and Italian Federation of Thrombosis Centers). Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study. Haematologica 2008; 93 (6) 900-907
27 Legnani C, Cini M, Cosmi B , et al. Age and gender specific cut-off values to improve the performance of D-dimer assays to predict the risk of venous thromboembolism recurrence. Intern Emerg Med 2013; 8 (3) 229-236
28 Baglin T, Palmer CR, Luddington R, Baglin C. Unprovoked recurrent venous thrombosis: prediction by D-dimer and clinical risk factors. J Thromb Haemost 2008; 6 (4) 577-582
29 Tosetto A, Iorio A, Marcucci M , et al. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost 2012; 10 (6) 1019-1025
30 Ageno W, Dentali F, Donadini MP, Squizzato A. Optimal treatment duration of venous thrombosis. J Thromb Haemost 2013; 11 (Suppl. 01) 151-160
31 Lippi G, Franchini M, Targher G, Favaloro EJ. Help me, Doctor! My D-dimer is raised. Ann Med 2008; 40 (8) 594-605
32 Hylek EM. Anticoagulation therapy for atrial fibrillation. Semin Thromb Hemost 2013; 39 (2) 147-152
33 Rojas-Hernandez CM, Garcia DA. The novel oral anticoagulants. Semin Thromb Hemost 2013; 39 (2) 117-126